[1] Kim JY,Cho Y,Oh E,et al. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer[J].Cancer Lett,2016,379(1):39-48.DOI:10.1016/j.canlet.2016.05.026.
[2] Martín M,Hinojar A,Cerezo L,et al. Aldehyde dehydrogenase isoform 1(ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer[J].Clin Transl Oncol,2016,18(8):825-830.DOI:10.1007/s12094-015-1445-1.
[3] Schfer A,Teufel J,Ringel F,et al. Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma[J].Neuro Oncol,2012,14(12):1452-1464.DOI:10.1093/neuonc/nos270.
[4] Kuang BH,Zhang MQ,Xu LH,et al. Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients′ overall survival[J].Br J Cancer,2013,109(5):1252-1263.DOI:10.1038/bjc.2013.439.
[5] Zhou Y,Wang Y,Ju X,et al. Clinicopathological significance of ALDH1A1 in lung,colorectal,and breast cancers:a meta-analysis[J].Biomark Med,2015,9(8):777-790.DOI:10.2217/BMM.15.49.
[6] Zhu W,Liu J,Nie J,et al. MG132 enhances the radiosensitivity of lung cancer cells in vitro and in vivo[J].Oncol Rep,2015,34(4):2083-2089.DOI:10.3892/or.2015.4169.
[7] You S,Li R,Park D,et al. Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer[J].Mol Cancer Ther,2014,13(3):606-616.DOI:10.1158/1535-7163.
[8] Oh SB,Hwang CJ,Song SY,et al. Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3[J].Cancer Lett,2014,353(1):95-103.DOI:10.1016/j.canlet.2014.07.007.
[9] Chen M,Wang X,Zha D,et al. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner[J].Sci Rep,2016,6:35468.DOI:10.1038/srep35468.